{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:33:51Z","timestamp":1771493631419,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p>The biological mechanisms responsible for the association of specific karyotypes with prognosis in acute myeloid leukaemia (AML) remain largely unclear. A prospective study was performed to evaluate how far cytogenetically defined prognostic subgroups of AML differ in their proliferative activity as a potential mechanism for differential sensitivities to S\u2010phase\u2010specific induction chemotherapy comprising cytosine arabinoside (AraC). One hundred and eighty\u2010seven patients with <jats:italic>de novo<\/jats:italic> AML were included in the study; 25 patients with a favourable [inv(16), t(8;21), t(15;17)] karyotype, 99 with a normal karyotype, 29 with an unfavourable karyotype (\u22125, 5q\u2013, \u22127, 7q\u2013, complex aberrations) and 34 with cytogenetic aberrations of unknown prognostic significance (all others). The favourable group demonstrated the highest <jats:italic>ex vivo<\/jats:italic> proliferative activity (PA) (3\u00b741\u2003pmol\/10<jats:sup>5<\/jats:sup> cells), significantly (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b702) exceeding the unfavourable group with the lowest PA (0\u00b772) and the group with a normal karyotype (1\u00b706) or with karyotype of unknown significance (1\u00b705) that both demonstrated an intermediate PA. Samples with a high PA (&gt; median of the whole group) were more likely to produce interleukin 3, granulocyte macrophage colony\u2010stimulating factor (GM\u2010CSF), granulocyte CSF (G\u2010CSF) (56%, 43% and 50%) than cells with a low PA (33%, 36% and 36%; n.s.). The effect of priming by exogenous GM\u2010CSF or G\u2010CSF was significantly more pronounced in samples with a low PA than in rapidly proliferating samples (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701). For the whole group, a high PA was closely associated with an increased incorporation of AraC triphosphate (AraCTP) into the DNA (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001). Clinically, a high PA was associated with a better complete remission (CR) rate in the normal (95% versus 62%) and the unfavourable group (75% versus 33%). The significant differences in proliferative activity between cytogenetic subgroups of AML are associated with increased cytosine arabinoside pharmacodynamics and constitute one potential mechanism for the different response of cytogenetic subgroups to AraC\u2010based induction therapy.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02866.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:34:39Z","timestamp":1047364479000},"page":"975-982","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia"],"prefix":"10.1111","volume":"113","author":[{"given":"Jan","family":"Braess","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerlinde","family":"Jahns\u2010Streubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Haase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fiegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhardt","family":"Schleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.1997.03540350075038","article-title":"World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects","volume":"277","author":"Anonymous","year":"1997","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(89)90025-3"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041480305"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.1071"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(84)80011-4"},{"key":"e_1_2_6_7_1","first-page":"57","article-title":"The treatment of adult acute myeloid leukemia","volume":"24","author":"Bishop J.F.","year":"1997","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.5.1710.1710"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02151.x"},{"key":"e_1_2_6_10_1","first-page":"4116","article-title":"Double induction strategy for acute myeloid leukemia: the effect of high\u2010dose cytarabine with mitoxantrone instead of standard\u2010dose cytarabine with daunorubicin and 6\u2010thioguanine: a randomized trial by the German AML Cooperative Group","volume":"93","author":"Buchner T.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201305"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.47.31534"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00962.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90113-D"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809068573"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990060109"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910260608"},{"key":"e_1_2_6_18_1","first-page":"1269","article-title":"Long\u2010term results following treatment of newly\u2010diagnosed acute myelogenous leukemia with continuous\u2010infusion high\u2010dose cytosine arabinoside","volume":"8","author":"Ghaddar H.M.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1182\/blood.V82.3.899.899","article-title":"Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia","volume":"82","author":"Hunter A.E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_20_1","first-page":"1857","article-title":"Blast cell proliferative activity and sensitivity to GM\u2010CSF in vitro are associated with early response to TAD\u20109 induction therapy in acute myeloid leukemia","volume":"9","author":"Jahns Streubel G.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.9.3579.bloodjournal8793579"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409114139"},{"key":"e_1_2_6_23_1","first-page":"172","article-title":"An in vitro model to predict clinical response in adult acute myelogenous leukemia","volume":"14","author":"Karp J.E.","year":"1987","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_24_1","first-page":"403","article-title":"Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome","volume":"2","author":"Keating M.J.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_6_25_1","first-page":"14","article-title":"[The prognostic significance of parameters of bone marrow blast cell proliferation in patients with acute leukemia] Prognosticheskoe znachenie parametrov proliferatsii blastnykh kletok kostnogo mozga u bol'nykh ostrym leikozom","volume":"34","author":"Kotel'Nikov V.M.","year":"1989","journal-title":"Gematological Transfuziology"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1016\/S0021-9258(19)70512-2","article-title":"Correlation of cytotoxicity with incorporation of ara\u2010C into DNA","volume":"255","author":"Kufe D.W.","year":"1980","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_27_1","first-page":"128","article-title":"Effects of 1\u2010beta\u2010d\u2010arabinofuranosylcytosine incorporation on eukaryotic DNA template function","volume":"26","author":"Kufe D.W.","year":"1984","journal-title":"Molecular Pharmacology"},{"key":"e_1_2_6_28_1","first-page":"647","article-title":"Interleukin\u20104 and interleukin\u20105 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del (5q)","volume":"73","author":"Le Beau M.M.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199303043280904"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.1997.15.12.3496","article-title":"Value of different modalities of granulocyte\u2010macrophage colony\u2010stimulating factor applied during or after induction therapy of acute myeloid leukemia","volume":"15","author":"Lowenberg B.","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_31_1","first-page":"17","article-title":"Clinical significance of cytogenetics in acute myeloid leukemia","volume":"24","author":"Mrozek K.","year":"1997","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_32_1","first-page":"904","article-title":"The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia","volume":"20","author":"Nara N.","year":"1992","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1986.tb02643.x"},{"key":"e_1_2_6_34_1","first-page":"6244","article-title":"1\u2010beta\u2010d\u2010arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of vivo murine tumor cell response","volume":"45","author":"Riva C.M.","year":"1985","journal-title":"Cancer Research"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11723"},{"key":"e_1_2_6_36_1","first-page":"485","article-title":"Parental origins of chromosome 7 loss in childhood monosomy 7 syndrome","volume":"8","author":"Savage P.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.3675.bloodjournal88103675"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02511.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07399.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(94)90174-0"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(84)80010-2"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03310.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.2841.bloodjournal8882841"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.13.6948"},{"key":"e_1_2_6_45_1","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.1996.14.7.2150","article-title":"Granulocyte\u2010macrophage colony\u2010stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group","volume":"14","author":"Zittoun R.","year":"1996","journal-title":"Journal of Clinical Oncology"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02866.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02866.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02866.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T21:14:45Z","timestamp":1697577285000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02866.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02866.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02866.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2002-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}